-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EK/LS7mVOTVhP9WfKA744gnZZOcKQxQgjAhO3LoIlNj4nrz9S4rnxicwLVKr1PNj cE0UZrZoDHLhTJ2kT0mhLQ== 0001013594-09-001463.txt : 20090729 0001013594-09-001463.hdr.sgml : 20090729 20090729174508 ACCESSION NUMBER: 0001013594-09-001463 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090727 FILED AS OF DATE: 20090729 DATE AS OF CHANGE: 20090729 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENDOLOGIX INC /DE/ CENTRAL INDEX KEY: 0001013606 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680328265 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 STUDEBAKER CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 9495957200 MAIL ADDRESS: STREET 1: 11 STUDEBAKER CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: RADIANCE MEDICAL SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19990122 FORMER COMPANY: FORMER CONFORMED NAME: CARDIOVASCULAR DYNAMICS INC DATE OF NAME CHANGE: 19960506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ELLIOTT ASSOCIATES, L.P. CENTRAL INDEX KEY: 0000904495 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28440 FILM NUMBER: 09971318 BUSINESS ADDRESS: STREET 1: 712 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125062999 MAIL ADDRESS: STREET 1: 712 FIFTH AVE CITY: NEW YORK STATE: NY ZIP: 10019 FORMER NAME: FORMER CONFORMED NAME: ELLIOTT ASSOCIATES LP DATE OF NAME CHANGE: 19930513 4 1 endofm4072909_ex.xml X0303 4 2009-07-27 0 0001013606 ENDOLOGIX INC /DE/ ELGX 0000904495 ELLIOTT ASSOCIATES, L.P. 712 FIFTH AVE NEW YORK NY 10019 0 0 1 0 Common Stock 2009-07-27 4 S 0 11295 4.9500 D 2521769 I See Common Stock 2009-07-27 4 S 0 2200 4.9550 D 2519569 I See Common Stock 2009-07-27 4 S 0 11360 4.9600 D 2508209 I See Common Stock 2009-07-27 4 S 0 2280 4.9650 D 2505929 I See Common Stock 2009-07-27 4 S 0 1360 4.9700 D 2504569 I See Common Stock 2009-07-27 4 S 0 2360 4.9800 D 2502209 I See Common Stock 2009-07-27 4 S 0 1040 4.9900 D 2501169 I See Common Stock 2009-07-27 4 S 0 5160 4.9950 D 2496009 I See Common Stock 2009-07-27 4 S 0 920 5.0000 D 2495089 I See Elliott Associates, L.P ("Elliott"). indirectly owns the 2,495,089 shares of Common Stock of Endologix, Inc. (the "Company") reported on this Form 4 through its subsidiary, The Liverpool Limited Partnership, a Bermuda limited partnership. On July 27, 2009, Elliott sold an aggregate of 37,975 shares of Common Stock of Endologix, Inc. (the "Company") as reported on this Form 4. Elliott does not currently have any plans to sell any additional shares of Common Stock of the Company, but reserves the right to do so as market conditions or other circumstances change. Elliot Greenberg, VP of Braxton Associates, Inc., as GP of Elliott Capital Advisors, L.P., as GP of Elliott Associates, L.P. 2009-07-29 -----END PRIVACY-ENHANCED MESSAGE-----